10x Genomics, Inc.
MX ˙ BMV ˙ US88025U1097
SecurityMX:TXG / 10x Genomics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership50,475 shares
Latest Disclosed Value $ 1,071,584
Citigroup Inc ownership in TXG / 10x Genomics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 50,475 shares of 10x Genomics, Inc. (MX:TXG) valued at $1,071,584 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 135,955 shares of 10x Genomics, Inc.. This represents a change in shares of -62.87% during the quarter.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (TXG) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:TXG / 10x Genomics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F 10X GENOMICS CL A COM 88025U109 50,475 -85,480 -62.87 1,072 -51.69 0.0002
2026-02-13 2025-12-31 13F 10X GENOMICS CL A COM 88025U109 135,955 -125,368 -47.97 2,217 -27.41 0.0010
2025-11-10 2025-09-30 13F 10X GENOMICS CL A COM 88025U109 261,323 93,104 55.35 3,055 56.86 0.0014
2025-08-11 2025-06-30 13F 10X GENOMICS CL A COM 88025U109 168,219 84,275 100.39 1,948 165.98 0.0010
2025-05-12 2025-03-31 13F 10X GENOMICS CL A COM 88025U109 83,944 -35,031 -29.44 733 -57.14 0.0004
2025-02-12 2024-12-31 13F 10X GENOMICS CL A COM 88025U109 118,975 103,089 648.93 1,708 377.09 0.0010
2024-11-12 2024-09-30 13F 10X GENOMICS CL A COM 88025U109 15,886 -8,048 -33.63 359 -23.01 0.0002
2024-08-12 2024-06-30 13F 10X GENOMICS CL A COM 88025U109 23,934 11,395 90.88 466 -1.06 0.0003
2024-05-10 2024-03-31 13F 10X GENOMICS CL A COM 88025U109 12,539 -36,699 -74.53 471 -82.94 0.0003
2024-02-09 2023-12-31 13F 10X GENOMICS CL A COM 88025U109 49,238 38,287 349.62 2,755 510.86 0.0019
2023-12-06 2023-09-30 13F/A-1 10X GENOMICS CL A COM 88025U109 10,951 5,317 94.37 452 43.63 0.0003
2023-11-09 2023-09-30 13F 10X GENOMICS CL A COM 88025U109 10,951 5,317 452 0.0001
2023-08-10 2023-06-30 13F 10X GENOMICS CL A COM 88025U109 5,634 552 10.86 315 10.95 0.0002
2023-05-11 2023-03-31 13F 10X GENOMICS CL A COM 88025U109 5,082 -16,137 -76.05 284 -63.39 0.0002
2023-02-09 2022-12-31 13F 10X GENOMICS CL A COM 88025U109 21,219 -5,313 -20.02 773 2.38 0.0006
2022-11-10 2022-09-30 13F 10X GENOMICS CL A COM 88025U109 26,532 -15,920 -37.50 755 -60.68 0.0005
2022-08-10 2022-06-30 13F 10X GENOMICS CL A COM 88025U109 42,452 -25,065 -37.12 1,920 -62.62 0.0014
2022-05-12 2022-03-31 13F 10X GENOMICS CL A COM 88025U109 67,517 1,388 2.10 5,137 -47.85 0.0031
2022-02-10 2021-12-31 13F 10X GENOMICS CL A COM 88025U109 66,129 -5,467 -7.64 9,851 -5.49 0.0053
2021-11-10 2021-09-30 13F 10X GENOMICS CL A COM 88025U109 71,596 -20,665 -22.40 10,423 -42.31 0.0062
2021-08-10 2021-06-30 13F 10X GENOMICS CL A COM 88025U109 92,261 18,372 24.86 18,067 35.09 0.0109
2021-05-13 2021-03-31 13F 10X GENOMICS CL A COM 88025U109 73,889 3,011 4.25 13,374 33.26 0.0087
2021-02-11 2020-12-31 13F 10X GENOMICS CL A COM 88025U109 70,878 21,725 44.20 10,036 63.77 0.0059
2020-11-12 2020-09-30 13F 10X GENOMICS CL A COM 88025U109 49,153 45,473 1,235.68 6,128 1,762.61 0.0040
2020-08-12 2020-06-30 13F 10X GENOMICS CL A COM 88025U109 3,680 2,912 379.17 329 585.42 0.0003
2020-05-12 2020-03-31 13F 10X GENOMICS CL A COM 88025U109 768 268 53.60 48 26.32 0.0000
2020-02-12 2019-12-31 13F 10X GENOMICS CL A COM 88025U109 500 500 38 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-05-11 2023-03-31 13F 10X GENOMICS CL A COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F 10X GENOMICS CL A COM Call 21,200 773 n/a n/a n/a
2022-11-10 2022-09-30 13F 10X GENOMICS CL A COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-10 2022-06-30 13F 10X GENOMICS CL A COM Call 120,200 95.13 5,439 16.07 n/a n/a n/a
2022-05-12 2022-03-31 13F 10X GENOMICS CL A COM Call 61,600 128.15 4,686 16.51 n/a n/a n/a
2022-02-10 2021-12-31 13F 10X GENOMICS CL A COM Call 27,000 4,022 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.